Showing posts from June, 2021

Prophylaxis for COVID-19 (Prevention Protocols) - FLCCC I-MASK+ and Zelenko 2021

Prophylaxis is a treatment given to prevent a disease. A prophylactic treatment is a treatment that you take while you are still healthy, in order to prevent getting ill. The main strategy for prevention endorsed by most health authorities is vaccination. Get vaccinated if possible. If you have not yet been vaccinated, the following prevention protocols have components that have been proven to reduce the risk of getting a COVID infection. FLCCC-I-MASK+ Prevention Protocol For prevention, the Front Line COVID-19 Critical Care Working Group (FLCCC) I-MASK+ protocol recommends (updated April 26, 2021): Vitamin D3 : 1000–3000 IU/day. Note RDA (Recommended Daily Allowance) is 800–1000 IU/day. The safe upper-dose daily limit is likely < 4000 IU/day. Vitamin D deficiency has been associated with an increased risk of acquiring COVID-19 and from dying from the disease. Vitamin D supplementation may therefore prove to be an effective and cheap intervention to lessen the impact of this disease

White Paper on Hydroxychloroquine 2021

In 2020, Hydroxychloroquine was touted as the most controversial drug in the world. Is there any new evidence to confirm or to disprove previous evidence? Hydroxychloroquine, Ivermectin, Vitamin D, Zinc and Azithromycin are among the handful of COVID-19 treatments that have been heavily studied as potential candidates that might influence the outcome in the prevention and management of COVID-19.  The purpose of this white paper is to present the updated evidence regarding the safety and efficacy of hydroxychloroquine and determine its proper role in the current pandemic. Database of all HCQ COVID-19 studies. 311 studies, 229 peer reviewed, 259 comparing treatment and control groups. HCQ is not effective when used very late with high dosages over a long period (RECOVERY/SOLIDARITY), effectiveness improves with earlier usage and improved dosing. Early treatment consistently shows positive effects. As you can clearly see above, all the early treatment results are all positive (upper left)

I-MASS: Prevention & At Home Treatment Mass Distribution Protocol for COVID-19

The FLCCC I-MASS Protocol was created for generalized distribution during mass outbreaks and in low-resource countries. To achieve maximal impact as well as ease of deployment with the lowest burden of required elements, the I-MASS treatment approach is centered on the fewest, core, high impact elements such as the drug Ivermectin, an anti-parasitic medicine that is on the WHO’s list of essential medicines, has been given 3.7 billion times around the globe, and has won the Nobel prize in 2015 for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world. Ivermectin has proven to be highly potent against COVID-19. It has shown antiviral and anti-inflammatory properties in observational and randomized controlled studies conducted throughout the world. Practitioners and Health Ministries who have adopted Ivermectin in treatment protocols report significant reductions in time to recovery, hospitalizations, and death. The use of Ivermectin as pro

Here’s How Fluvoxamine Might Help Prevent COVID-19 Infections From Getting Worse

Fluvoxamine, developed 40 years ago as an antidepressant —sometimes known as Luvox—has been used mainly to treat obsessive-compulsive disorder (OCD), per the  National Alliance on Mental Illness   (NAMI). But now, researchers are taking a closer look at how the medication could be an important treatment to prevent patients who test positive for COVID-19 from getting seriously ill with the infection. In a new interview with  60 Minutes , Angela Reiersen, MD, a child psychiatrist at Washington University in St. Louis—and co-author of a November 2020 study published in the  Journal of the American Medical Association  (JAMA)  regarding the use of fluvoxamine in COVID-19 patients—explained that she first got the idea that the drug could potentially treat COVID-19 after seeing  research  that fluvoxamine prevented sepsis in mice. "I thought, well, I wonder if we could use fluvoxamine to treat COVID and prevent that clinical deterioration," Dr. Reiersen told  60 Minutes . Dr. Reie

Global adoption of COVID-19 early treatments (2021)

Credit: Argentina Ivermectin - unofficial - mixed usage - Jan 26, 2021   (Internet Archive)   (Internet Archive)   (Internet Archive)   (Internet Archive)   (Internet Archive)   (Internet Archive) Bahrain (Hydroxy)chloroquine - official - country-wide adoption   (Internet Archive)   (Internet Archive)


Show more